A61K 2800/782
Enzyme inhibitors
Official title: Enzyme inhibitors; Enzyme antagonists
A61K2800/782 (Enzyme inhibitors) appears on 562 US grants and 824 published applications in this corpus.
Search patents in A61K- Granted patents
- 562
- Published applications
- 824
- Assignees
- 374
- Inventors
- 1,613
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 12 | 0 |
| 1996 | 10 | 0 |
| 1997 | 14 | 0 |
| 1998 | 17 | 0 |
| 1999 | 14 | 0 |
| 2000 | 21 | 0 |
| 2001 | 19 | 4 |
| 2002 | 17 | 27 |
| 2003 | 14 | 45 |
| 2004 | 7 | 62 |
| 2005 | 6 | 48 |
| 2006 | 13 | 29 |
| 2007 | 16 | 37 |
| 2008 | 8 | 40 |
| 2009 | 8 | 32 |
| 2010 | 19 | 34 |
| 2011 | 15 | 31 |
| 2012 | 13 | 39 |
| 2013 | 26 | 37 |
| 2014 | 29 | 41 |
| 2015 | 25 | 42 |
| 2016 | 24 | 26 |
| 2017 | 28 | 56 |
| 2018 | 21 | 20 |
| 2019 | 23 | 23 |
| 2020 | 14 | 23 |
| 2021 | 22 | 17 |
| 2022 | 14 | 26 |
| 2023 | 15 | 21 |
| 2024 | 14 | 29 |
| 2025 | 17 | 21 |
| 2026 | 10 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Topical composition against fine lines and wrinkles22 Sep 2026US 12,740,938 B2Mary Kay Inc.
- Magnolia extract containing compositions25 Aug 2026US 12,714,657 B2Mary Kay Inc.
- Topical skin care formulations comprising plant extracts25 Aug 2026US 12,714,664 B2Mary Kay Inc.
- Composition for preventing hair loss and promoting hair growth comprising postbiotic components from heat-treat Limosilactobacillus fermentum LM10204 Aug 2026US 12,697,359 B2Lactomason Co., Ltd.
- Fermented apple composition9 Jun 2026US 12,648,902 B2Cj Cheiljedang Corporation
- Topical skin care formulations comprising plant extracts8 Oct 2026US 2026/0306366 A1Mary Kay Inc.
- Formulations of naringenin1 Oct 2026US 2026/0294770 A1Debut Biotechnology, Inc.
- Anti-Inflammatory Bio-Active Collagen Hybridizing Peptides and Methods of Using Thereof13 Aug 2026US 2026/0234215 A13Helix, Inc.
- Cosmetic composition for enhancing resistance to aging30 Jul 2026US 2026/0216052 A1L'oreal
- Formulations for substituted 3-pyrrolidines, compositions containing, and uses of same16 Jul 2026US 2026/0199332 A1Lipidio Pharmaceuticals, Inc.
Most cited
By later US patents
- Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen267US 6,676,655 B2Light BioScience, LLC · 2004
- Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same110US 5,733,558 AL'oreal · 1998
- Method for regulating hair growth96US 6,451,777 B1The University of Texas Southwestern Medical Center · 2002
- No-synthase inhibitors96US 7,083,799 B1L'oreal · 2006
- Method for regulating hair growth74US 6,124,362 AThe Procter & Gamble Company · 2000